JP2025114869A5 - - Google Patents
Info
- Publication number
- JP2025114869A5 JP2025114869A5 JP2025086115A JP2025086115A JP2025114869A5 JP 2025114869 A5 JP2025114869 A5 JP 2025114869A5 JP 2025086115 A JP2025086115 A JP 2025086115A JP 2025086115 A JP2025086115 A JP 2025086115A JP 2025114869 A5 JP2025114869 A5 JP 2025114869A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic composition
- premature infant
- administered
- pma
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762557113P | 2017-09-11 | 2017-09-11 | |
| US62/557,113 | 2017-09-11 | ||
| JP2020514518A JP7819893B2 (ja) | 2017-09-11 | 2018-09-11 | 慢性肺疾患を治療するための方法および組成物 |
| PCT/US2018/050427 WO2019051474A1 (en) | 2017-09-11 | 2018-09-11 | METHODS AND COMPOSITIONS FOR TREATING CHRONIC PULMONARY DISEASES |
| JP2023125304A JP2023145646A (ja) | 2017-09-11 | 2023-08-01 | 慢性肺疾患を治療するための方法および組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023125304A Division JP2023145646A (ja) | 2017-09-11 | 2023-08-01 | 慢性肺疾患を治療するための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025114869A JP2025114869A (ja) | 2025-08-05 |
| JP2025114869A5 true JP2025114869A5 (enExample) | 2025-10-20 |
Family
ID=63794620
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020514518A Active JP7819893B2 (ja) | 2017-09-11 | 2018-09-11 | 慢性肺疾患を治療するための方法および組成物 |
| JP2023125304A Pending JP2023145646A (ja) | 2017-09-11 | 2023-08-01 | 慢性肺疾患を治療するための方法および組成物 |
| JP2025086115A Pending JP2025114869A (ja) | 2017-09-11 | 2025-05-23 | 慢性肺疾患を治療するための方法および組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020514518A Active JP7819893B2 (ja) | 2017-09-11 | 2018-09-11 | 慢性肺疾患を治療するための方法および組成物 |
| JP2023125304A Pending JP2023145646A (ja) | 2017-09-11 | 2023-08-01 | 慢性肺疾患を治療するための方法および組成物 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20190151411A1 (enExample) |
| EP (2) | EP4663184A3 (enExample) |
| JP (3) | JP7819893B2 (enExample) |
| KR (1) | KR20200097679A (enExample) |
| CN (1) | CN111432881A (enExample) |
| AU (2) | AU2018328827B2 (enExample) |
| BR (1) | BR112020004760A2 (enExample) |
| CA (1) | CA3075482A1 (enExample) |
| CL (1) | CL2020000597A1 (enExample) |
| CO (1) | CO2020004244A2 (enExample) |
| EA (1) | EA202090705A1 (enExample) |
| EC (1) | ECSP20055797A (enExample) |
| IL (1) | IL273174B2 (enExample) |
| MX (1) | MX421623B (enExample) |
| MY (1) | MY204825A (enExample) |
| PE (1) | PE20201166A1 (enExample) |
| PH (1) | PH12020500489A1 (enExample) |
| SG (1) | SG11202002088TA (enExample) |
| UA (1) | UA128690C2 (enExample) |
| WO (1) | WO2019051474A1 (enExample) |
| ZA (1) | ZA202001568B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3005966T3 (en) * | 2020-10-19 | 2025-03-17 | Oak Hill Bio Ltd | Compositions suitable for use in neonates |
| IL316413A (en) * | 2022-05-04 | 2024-12-01 | Oak Hill Bio Ltd | Combination therapy for preterm infants |
| WO2023242440A1 (en) * | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Treament of lungs in infants |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL71991A (en) | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
| AU627423B2 (en) | 1987-04-06 | 1992-08-27 | Celtrix Pharmaceuticals, Inc. | Human somatomedin carrier protein subunits and process for producing them |
| DK131988A (da) | 1988-03-11 | 1989-09-12 | Erasmus University | Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur |
| US5258287A (en) | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
| DE3854842T2 (de) | 1988-04-12 | 1996-06-13 | Amgen Boulder Inc | Verfahren zur steigerung und zur hemmung der wirkung eines insulinähnlichen wachstumfaktors |
| GB8826451D0 (en) | 1988-11-11 | 1988-12-14 | Sandoz Ltd | Improvements in/relating to organic compounds |
| IL92816A0 (en) | 1988-12-22 | 1990-09-17 | Biogrowth Inc | Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides |
| AU4238493A (en) | 1992-05-08 | 1993-12-13 | Thomas Jefferson University | IGF-1 analogs |
| US5563046A (en) | 1993-08-02 | 1996-10-08 | Celtrix Pharmaceuticals, Inc. | Fusion polypeptides and proteins |
| US5789547A (en) | 1995-06-07 | 1998-08-04 | Celtrix Pharmaceuticals, Inc. | Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding |
| US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
| AU2002239560B2 (en) * | 2000-11-28 | 2006-03-02 | Premacure Ab | Determination of risk and treatment of complications of prematurity |
| US8518877B2 (en) * | 2007-04-18 | 2013-08-27 | Premacure Ab | Method and product for treatment and/or prevention of complications of prematurity |
-
2018
- 2018-09-11 KR KR1020207009049A patent/KR20200097679A/ko not_active Ceased
- 2018-09-11 BR BR112020004760-0A patent/BR112020004760A2/pt unknown
- 2018-09-11 EP EP25211426.9A patent/EP4663184A3/en active Pending
- 2018-09-11 MX MX2020002744A patent/MX421623B/es unknown
- 2018-09-11 PE PE2020000320A patent/PE20201166A1/es unknown
- 2018-09-11 EP EP18783187.0A patent/EP3681602B1/en active Active
- 2018-09-11 US US16/127,988 patent/US20190151411A1/en not_active Abandoned
- 2018-09-11 UA UAA202002323A patent/UA128690C2/uk unknown
- 2018-09-11 MY MYPI2020001266A patent/MY204825A/en unknown
- 2018-09-11 WO PCT/US2018/050427 patent/WO2019051474A1/en not_active Ceased
- 2018-09-11 EA EA202090705A patent/EA202090705A1/ru unknown
- 2018-09-11 IL IL273174A patent/IL273174B2/en unknown
- 2018-09-11 CA CA3075482A patent/CA3075482A1/en active Pending
- 2018-09-11 CN CN201880058512.XA patent/CN111432881A/zh active Pending
- 2018-09-11 SG SG11202002088TA patent/SG11202002088TA/en unknown
- 2018-09-11 JP JP2020514518A patent/JP7819893B2/ja active Active
- 2018-09-11 AU AU2018328827A patent/AU2018328827B2/en active Active
-
2020
- 2020-03-09 CL CL2020000597A patent/CL2020000597A1/es unknown
- 2020-03-11 PH PH12020500489A patent/PH12020500489A1/en unknown
- 2020-03-12 ZA ZA2020/01568A patent/ZA202001568B/en unknown
- 2020-04-07 CO CONC2020/0004244A patent/CO2020004244A2/es unknown
- 2020-09-08 EC ECSENADI202055797A patent/ECSP20055797A/es unknown
-
2021
- 2021-05-11 US US17/317,152 patent/US20220088132A1/en active Pending
-
2023
- 2023-08-01 JP JP2023125304A patent/JP2023145646A/ja active Pending
-
2024
- 2024-08-30 US US18/821,397 patent/US20240415927A1/en active Pending
- 2024-10-24 AU AU2024227601A patent/AU2024227601B2/en active Active
-
2025
- 2025-05-23 JP JP2025086115A patent/JP2025114869A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20080248999A1 (en) | Amylin formulations | |
| EP0921812B2 (en) | Insulin preparations containing a halogenide | |
| JP2023550203A5 (enExample) | ||
| JP2813017B2 (ja) | 癌療法の副作用の減少方法 | |
| JP2961045B2 (ja) | 腸管粘膜増強促進剤 | |
| WO2003094951A1 (en) | Soluble formulations comprising insulin aspart and insulin detemir | |
| ZA200600846B (en) | Novel insulin derivatives | |
| CN106232141A (zh) | 针对由给予类固醇诱发的生长不足的药物 | |
| JP2004501870A (ja) | ガン患者における化学療法の副作用を軽減させる方法 | |
| JPS63303930A (ja) | インシユリンおよびインシユリン誘導体の混合結晶 | |
| CN118234504A (zh) | 治疗剂的口服递送 | |
| US5198422A (en) | Stabilized somatotropin for parenteral administration | |
| JP2020533344A5 (enExample) | ||
| JP2024506145A5 (enExample) | ||
| GB2244918A (en) | Pharmaceutical compositions comprising somatosatin and cholanic acid derivatives | |
| US4963529A (en) | Stable growth hormone releasing factor preparation | |
| Hashizume et al. | Prader‐Willi Syndrome with del (15)(q1l, q13) Associated with Hepatoblastoma | |
| JP2023510609A (ja) | Ｇｌｐ－１および／またはｇｌｐ－１類似体、ならびにインスリンおよび／またはインスリン類似体を含む併用療法 | |
| US6153581A (en) | Drug for recovering renal function | |
| AU650050B2 (en) | Product and use of it for the treatment of catabolic states comprising authentic IGF-1 and hypocaloric amount of nutritients | |
| JP2025502349A (ja) | Ｉｇｆ－１／ｉｇｆｂｐの酸化を低減するための組成物および方法 | |
| JP4023863B2 (ja) | Ｉｌ−６を含む血清尿酸値低下剤 | |
| JP5034944B2 (ja) | インターフェロン作用物質の活性増強剤 | |
| US3102844A (en) | Oral iron-glucosamine hematinic composition and therapy | |
| US20250361201A1 (en) | N-[8-(2-hydroxybenzoyl)amino]potassium octanoate crystal polymorph, and preparation method therefor and use thereof |